Mihai DP, Ungurianu A, Ciotu CI, Fischer MJM, Olaru OT, Nitulescu GM, Andrei C, Zbarcea CE, Zanfirescu A, Seremet OC, Chirita C, Negres S. Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress. Int J Mol Sci 2021;22:7183. [PMID: 34281235 DOI: 10.3390/ijms22137183][Cited by in Crossref: 2][Cited by in F6Publishing: 2][Article Influence: 1.0][Reference Citation Analysis]
Andrei C, Mihai DP, Zanfirescu A, Nitulescu GM, Negres S. In Silico Drug Repurposing Framework Predicts Repaglinide, Agomelatine and Protokylol as TRPV1 Modulators with Analgesic Activity. Pharmaceutics 2022;14. [PMID: 36559057 DOI: 10.3390/pharmaceutics14122563][Reference Citation Analysis]
3
Zhao Z, Zheng R, Wang X, Li T, Dong X, Zhao C, Li X. Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination. Front Aging Neurosci 2022;14:870957. [DOI: 10.3389/fnagi.2022.870957][Reference Citation Analysis]
4
Abdelzaher WY, Nassan MA, Ahmed SM, Welson NN, El-saber Batiha G, Khalaf HM. Xanthine Oxidase Inhibitor, Febuxostat Is Effective against 5-Fluorouracil-Induced Parotid Salivary Gland Injury in Rats Via Inhibition of Oxidative Stress, Inflammation and Targeting TRPC1/CHOP Signalling Pathway. Pharmaceuticals 2022;15:232. [DOI: 10.3390/ph15020232][Cited by in Crossref: 1][Cited by in F6Publishing: 1][Article Influence: 1.0][Reference Citation Analysis]
